[Federal Register Volume 78, Number 54 (Wednesday, March 20, 2013)]
[Notices]
[Page 17229]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-06360]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE


Notice of Lodging of Proposed Consent Decree Amendment Under the 
Clean Air Act; the Clean Water Act; the Resource Conservation and 
Recovery Act; the Missouri Air Conservation Law; the Missouri Clean 
Water Law and the Missouri Hazardous Waste Management Law

    On March 14, 2013, the Department of Justice and the State of 
Missouri lodged with the United States District Court for the Eastern 
District of Missouri a consent decree in the lawsuit entitled United 
States v. Teva Pharmaceuticals USA, Inc. 2:13-cv-00027-HEA.
    The lawsuit is a civil action brought pursuant to the Clean Air 
Act, the Missouri Air Conservation Law, the Clean Water Act, the 
Missouri Clean Water Law, the Resource Conservation and Recovery Act, 
and the Missouri Hazardous Waste Management Law. The complaint seeks 
civil penalties and injunctive relief against Teva Pharmaceuticals USA, 
Inc., for violations of the requirements applicable to hazardous air 
pollutants and hazardous waste, and of requirements applicable to 
Teva's discharge of pollutants to a city-owned wastewater treatment 
plant. The violations occurred at a chemical manufacturing facility 
located in Mexico, Missouri.
    The consent decree requires Teva to pay a civil penalty of 
$2,250,000 and to implement a series of projects and changes at its 
Mexico Facility to bring the facility into compliance and mitigate its 
past violations. Among other things, Teva will be required to develop a 
pretreatment plan; conduct vacuum stripping of wastewater streams to 
remove methylene chloride; install an automated diffused aeration rate 
system in its wastewater treatment plant; implement an enhanced leak 
detection program; and establish an Environmental Management System 
that calls for environmental audits of its facility.
    This publication opens a period for public comment on the Consent 
Decree. You may submit comments to the Assistant Attorney General, 
Environment and Natural Resources Division. The comments should refer 
to United States v. Teva Pharmaceuticals USA, Inc., D.J. Ref. No. 90-5-
2-1-09638. Comments must be submitted no later than thirty (30) days 
after the publication date of this notice. Forward comments either by 
email or U.S. mail:

------------------------------------------------------------------------
          To submit comments:                     Send them to:
------------------------------------------------------------------------
By e-mail.............................  [email protected].
By U.S. mail..........................  Assistant Attorney General, U.S.
                                         DOJ--ENRD, P.O. Box 7611,
                                         Washington, DC 20044-7611.
------------------------------------------------------------------------

    During the public comment period, Consent Decree may be examined 
and downloaded at this Justice Department Web site: http://www.usdoj.gov/enrd/Consent_Decrees.html. We will provide a paper copy 
of the Consent Decree upon written request and payment of reproduction 
costs. Please mail your request and payment to: Consent Decree Library, 
U.S. DOJ--ENRD, P.O. Box 7611, Washington, DC 20044-7611.
    Please enclose a check or money order for $20.25 (25 cents per page 
reproduction cost) payable to the United States Treasury.

Robert M. Maher, Jr.,
Assistant Section Chief, Environmental Enforcement Section, Environment 
and Natural Resources Division.
[FR Doc. 2013-06360 Filed 3-19-13; 8:45 am]
BILLING CODE 4410-15-P